You have 9 free searches left this month | for more free features.

saracatinib

Showing 1 - 20 of 20

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer's Disease Trial in New Haven (saracatinib, Placebo)

Completed
  • Alzheimer's Disease
  • saracatinib
  • Placebo
  • New Haven, Connecticut
    Yale Alzheimer's Disease Research Unit
Apr 22, 2021

Alcohol Drinking Trial in New Haven (Saracatinib, Placebos)

Completed
  • Alcohol Drinking
  • Saracatinib
  • Placebos
  • New Haven, Connecticut
    CMHC, Substance Abuse Center
Oct 20, 2020

Pulmonary Lymphangioleiomyomatosis Trial in United States (saracatinib)

Terminated
  • Pulmonary Lymphangioleiomyomatosis
  • saracatinib
  • Stanford, California
  • +4 more
Jul 28, 2020

Osteosarcoma Trial in United States (Saracatinib, Placebo)

Terminated
  • Osteosarcoma
  • Saracatinib
  • Placebo
  • Birmingham, Alabama
  • +17 more
Jan 7, 2020

Alcohol Drinking Trial in New Haven (Saracatinib)

Completed
  • Alcohol Drinking
  • Saracatinib
  • New Haven, Connecticut
    CMHC, Substance Abuse Center
Jan 10, 2020

Parkinson Disease Psychosis Trial in London (Saracatinib, Placebo Oral Tablet)

Unknown status
  • Parkinson Disease Psychosis
  • Saracatinib
  • Placebo Oral Tablet
  • London, Camberwell, United Kingdom
    Mitul Mehta
Aug 12, 2019

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in Houston (saracatinib, laboratory

Terminated
  • Adenocarcinoma of the Colon
  • +5 more
  • saracatinib
  • laboratory biomarker analysis
  • Houston, Texas
    M D Anderson Cancer Center
Jul 29, 2019

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Australia, Singapore, United

Completed
  • Adenocarcinoma of the Pancreas
  • +2 more
  • saracatinib
  • +5 more
  • Scottsdale, Arizona
  • +8 more
Mar 20, 2019

Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Gastric Cancer Trial in Canada, United

Completed
  • Adenocarcinoma of the Gastroesophageal Junction
  • +6 more
  • saracatinib
  • Dalton, Georgia
  • +4 more
Jul 26, 2018

Cancer Trial in Sheffield (Saracatinib, Placebo)

Completed
  • Cancer
  • Saracatinib
  • Placebo
  • Sheffield, South Yorkshire, United Kingdom
    Sheffield Teaching Hospitals NHS Trust
Apr 12, 2018

Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Duarte (saracatinib, laboratory biomarker analysis)

Completed
  • Hormone-resistant Prostate Cancer
  • Recurrent Prostate Cancer
  • saracatinib
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope
Mar 21, 2018

Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma Trial in Canada, United States (saracatinib)

Completed
  • Adult Fibrosarcoma
  • +14 more
  • saracatinib
  • Rockledge, Pennsylvania
  • +3 more
May 29, 2018

Extensive Stage Small Cell Lung Cancer, Lung Metastases, Malignant Pleural Effusion Trial in Rochester (saracatinib)

Completed
  • Extensive Stage Small Cell Lung Cancer
  • +3 more
  • saracatinib
  • Rochester, Minnesota
    North Central Cancer Treatment Group
Nov 2, 2017

Pulmonary Lymphangioleiomyomatosis Trial in Cincinnati, Houston (Saracatinib)

Completed
  • Pulmonary Lymphangioleiomyomatosis
  • Saracatinib
  • Cincinnati, Ohio
  • +2 more
Nov 28, 2016

Invasive Thymoma and Thymic Carcinoma, Recurrent Thymoma and Thymic Carcinoma, Stage III Thymoma Trial in Stanford, Indianapolis

Terminated
  • Invasive Thymoma and Thymic Carcinoma
  • +4 more
  • saracatinib
  • Stanford, California
  • +1 more
Jun 5, 2015

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in United Kingdom (Paclitaxel, Saracatinib, Matched )

Completed
  • Ovarian Cancer
  • +2 more
  • Cambridge, Cambridgeshire, United Kingdom
  • +11 more
Apr 17, 2015

Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in United States (saracatinib,

Terminated
  • Hormone-resistant Prostate Cancer
  • +2 more
  • saracatinib
  • hydrocortisone/placebo
  • Chicago, Illinois
  • +14 more
Mar 18, 2015

Recurrent Melanoma, Stage IIA Melanoma, Stage IIB Melanoma Trial in Chicago (saracatinib)

Completed
  • Recurrent Melanoma
  • +4 more
  • saracatinib
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
May 6, 2014

Estrogen Receptor-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in New York

Completed
  • Estrogen Receptor-negative Breast Cancer
  • +6 more
  • saracatinib
  • laboratory biomarker analysis
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 2, 2014

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +38 more
  • saracatinib
  • laboratory biomarker analysis
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 2, 2014